396
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Future directions in stenting

, , &
Pages 1-6 | Published online: 10 Jan 2014

Figures & data

Figure 1. Histological sections showing stent thrombosis in a patient with acute myocardial infaction.

An 81-year-old male died suddenly 2 months after Taxus™ stent implantation in the left anterior descending artery for acute myocardial infaction. (A) Radiograph showing the area of plaque rupture (C, D & E) with three histologic sections. (B & D) Low-power sections of site of plaque rupture with (F) corresponding high powers. Note absence of fibrous cap and lack of stent coverage with overlay platelet-rich thrombus mixed with red cells. (D & E) Nonculprit sites with neointimal coverage of stent struts (boxed areas) and (G & B) persistant fibrin deposition. (E & H) Low and high powers of adjoining area of calcification at the site of plaque rupture (arrow). (H) Note fibrin coverage of stent struts, which are overlying an area of calcification with luminal platelet rich thrombus.

Figure 1. Histological sections showing stent thrombosis in a patient with acute myocardial infaction.An 81-year-old male died suddenly 2 months after Taxus™ stent implantation in the left anterior descending artery for acute myocardial infaction. (A) Radiograph showing the area of plaque rupture (C, D & E) with three histologic sections. (B & D) Low-power sections of site of plaque rupture with (F) corresponding high powers. Note absence of fibrous cap and lack of stent coverage with overlay platelet-rich thrombus mixed with red cells. (D & E) Nonculprit sites with neointimal coverage of stent struts (boxed areas) and (G & B) persistant fibrin deposition. (E & H) Low and high powers of adjoining area of calcification at the site of plaque rupture (arrow). (H) Note fibrin coverage of stent struts, which are overlying an area of calcification with luminal platelet rich thrombus.
Figure 2. Representive histological sections of Bioabsorbable Vascular Solutions stent in pig coronary arteries removed at (A) 1 month and (D) 36 months (EVG staining).

(B & E) High-power images of strut regions (H & E) showing presence of fibrin at 1 month and absence at 36 months. Note the strut outline is barely visible at 36 months. α actin-positive smooth muscle cells are observed in the neointima and media at (C) 1 month and (F) 36 months. (G) Complete degradation of the polymer strut with surrounding basophilic deposition of calcium (H & E). (H) Alcian blue positive proteoglycan infiltrated the matrix of the Bioabsorbable Vascular Solutions stent stent strut. (I) Calcification is seen around the degraded stent strut (von Kossa).

Modified and reproduced with permission from Citation[18].

Figure 2. Representive histological sections of Bioabsorbable Vascular Solutions stent in pig coronary arteries removed at (A) 1 month and (D) 36 months (EVG staining).(B & E) High-power images of strut regions (H & E) showing presence of fibrin at 1 month and absence at 36 months. Note the strut outline is barely visible at 36 months. α actin-positive smooth muscle cells are observed in the neointima and media at (C) 1 month and (F) 36 months. (G) Complete degradation of the polymer strut with surrounding basophilic deposition of calcium (H & E). (H) Alcian blue positive proteoglycan infiltrated the matrix of the Bioabsorbable Vascular Solutions stent stent strut. (I) Calcification is seen around the degraded stent strut (von Kossa).Modified and reproduced with permission from Citation[18].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.